The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized phase II study of preoperative concurrent chemoradiotherapy with or without induction chemotherapy with S-1 and oxaliplatin in patients with resectable esophageal cancer.
Dok Hyun Yoon
No relevant relationships to disclose
Geundoo Jang
No relevant relationships to disclose
Jong Hoon Kim
No relevant relationships to disclose
Yong Hee Kim
No relevant relationships to disclose
Seyoung Son
No relevant relationships to disclose
Jiyoun KIM
No relevant relationships to disclose
Seung-Il Park
No relevant relationships to disclose
Hyeong Ryul Kim
No relevant relationships to disclose
Hwoon-Yong Jung
No relevant relationships to disclose
Gin-Hyug Lee
No relevant relationships to disclose
Kee Don Choi
No relevant relationships to disclose
Ho June Song
No relevant relationships to disclose
Ho Young Song
No relevant relationships to disclose
Ji Hoon Shin
No relevant relationships to disclose
Kyung-Ja Cho
No relevant relationships to disclose
Sung-Bae Kim
No relevant relationships to disclose